# DOXORUBICIN HYDROCHLORIDE
> **ANDA091495** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS · Approved 2013-03-18
## Drug
- **FDA Application Number:** ANDA091495
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXORUBICIN HYDROCHLORIDE
- **Generic name:** Doxorubicin Hydrochloride
- **Active ingredients:** DOXORUBICIN HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS
- **First approval:** 2013-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091495)
---
*AI Analytics · CC0 1.0*